Best of ASCO - 2014 Annual Meeting

 

Welcome

Cancer Angiogenesis and Metastases

Developmental Therapeutics and Tumor Biology (Nonimmuno)

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.

Nancy Chan

3021

Clinical assessment of tumor angiogenesis and its predictive value for chemotherapy responses of colorectal metastatic hepatic tumors.

Hirotaka Okamoto

e14505

Correlation betwen MKK4 expression (exp) and clinicopathological features, KRAS/NRAS mutation in metastatic colorectal cancer (mCRC).

Mutlu Dogan

e14500

Effect of ligand binding domain activating mutations of ESR1 on cellular metabolism, liver tropism, and chemotherapy resistance.

Ido Wolf

e14506

Exceptional responders to abexinostat (ABX) plus pazopanib (PAZ) in pretreated renal cell carcinoma (RCC) and other solid tumors: Long-term follow-up of a phase 1b study.

Rahul Raj Aggarwal

3022

Genes copy number variation in tumor cells of patients with metastatic and non-metastatic lung adenocarcinoma.

Denis S. Kutilin

e14502

High dose apatinib in the reversal of immunosuppressive tumor microenvironment for irradiation therapy in lung carcinoma.

Lijun Liang

e14503

Phase 1a study results investigating the safety and preliminary efficacy of ABL001 (NOV1501), a bispecific antibody targeting VEGF and DLL4 in metastatic gastrointestinal (GI) cancer.

Jeeyun Lee

3023

Role of metabolic reprogramming toward fatty acid oxidation on tumor lymph node metastasis.

Choong-kun Lee

e14501

The relationship between mesenchymal stem cells, monocyte-macrophages, endothelial progenitor cells, and prognosis of hepatocellular carcinoma.

Kun Yan

e14507